Thrush and fever as measures of immunocompetence in HIV-1-infected men

Alison J. Kirby, Alvaro Munoz, Roger Detels, John A. Armstrong, Alfred Saah, John P. Phair

Research output: Contribution to journalArticle

Abstract

The occurrence of Pneumocystis carinii pneumonia (PCP) in human immunodeficiency virus type 1 (HIV-1)-infected individuals with high CD4+ counts indicates poor immunologic function. Thrush and persistent fever, easily recognized clinically, are potential measures of immunocompetence. This analysis establishes the complex interactions of CD4+ count, thrush, and persistent fever to predict the occurrence of PCP. Analyses used 20,632 person visits from 2,568 HIV-1-seropositive homosexual or bisexual men participating in the Multicenter AIDS Cohort Study (MACS). Comprehensive examinations were conducted semiannually, while occurrences of PCP were assessed continuously. The occurrence of thrush and fever increase in frequency as CD4+ levels decrease. The relative hazard of PCP in the presence of thrush compared with the absence of thrush rises (p <0.05) from 1 for the lowest CD4+ category to approximately 5 in the highest categories. The relative hazard of PCP in thepresence of fever compared with the absence of fever is above one (p <0.05) in all CD4+ categories. No cases of PCP occurred in individuals on PCP prophylaxis with CD4+ counts >200/mm3. These results suggest that HIV-1-related symptoms provide a measure of failing immune function that is not reflected by enumeration of CD4+ lymphocytes alone and support the United States Public Health Service recommendation that symptomatic individuals with CD4+ counts >200/mm3 should be considered for PCP prophylaxis.

Original languageEnglish (US)
Pages (from-to)1242-1249
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume7
Issue number12
StatePublished - 1994

Fingerprint

Oral Candidiasis
Immunocompetence
Pneumocystis Pneumonia
HIV-1
Fever
CD4 Lymphocyte Count
United States Public Health Service
Acquired Immunodeficiency Syndrome
Cohort Studies
Lymphocytes

Keywords

  • Candida
  • Cohort studies
  • Fever
  • Pneumocystis carinii pneumonia

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Virology
  • Immunology and Allergy

Cite this

Kirby, A. J., Munoz, A., Detels, R., Armstrong, J. A., Saah, A., & Phair, J. P. (1994). Thrush and fever as measures of immunocompetence in HIV-1-infected men. Journal of Acquired Immune Deficiency Syndromes, 7(12), 1242-1249.

Thrush and fever as measures of immunocompetence in HIV-1-infected men. / Kirby, Alison J.; Munoz, Alvaro; Detels, Roger; Armstrong, John A.; Saah, Alfred; Phair, John P.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 7, No. 12, 1994, p. 1242-1249.

Research output: Contribution to journalArticle

Kirby, AJ, Munoz, A, Detels, R, Armstrong, JA, Saah, A & Phair, JP 1994, 'Thrush and fever as measures of immunocompetence in HIV-1-infected men', Journal of Acquired Immune Deficiency Syndromes, vol. 7, no. 12, pp. 1242-1249.
Kirby, Alison J. ; Munoz, Alvaro ; Detels, Roger ; Armstrong, John A. ; Saah, Alfred ; Phair, John P. / Thrush and fever as measures of immunocompetence in HIV-1-infected men. In: Journal of Acquired Immune Deficiency Syndromes. 1994 ; Vol. 7, No. 12. pp. 1242-1249.
@article{80cfbb112b344a81bf4f259d0e7cb063,
title = "Thrush and fever as measures of immunocompetence in HIV-1-infected men",
abstract = "The occurrence of Pneumocystis carinii pneumonia (PCP) in human immunodeficiency virus type 1 (HIV-1)-infected individuals with high CD4+ counts indicates poor immunologic function. Thrush and persistent fever, easily recognized clinically, are potential measures of immunocompetence. This analysis establishes the complex interactions of CD4+ count, thrush, and persistent fever to predict the occurrence of PCP. Analyses used 20,632 person visits from 2,568 HIV-1-seropositive homosexual or bisexual men participating in the Multicenter AIDS Cohort Study (MACS). Comprehensive examinations were conducted semiannually, while occurrences of PCP were assessed continuously. The occurrence of thrush and fever increase in frequency as CD4+ levels decrease. The relative hazard of PCP in the presence of thrush compared with the absence of thrush rises (p <0.05) from 1 for the lowest CD4+ category to approximately 5 in the highest categories. The relative hazard of PCP in thepresence of fever compared with the absence of fever is above one (p <0.05) in all CD4+ categories. No cases of PCP occurred in individuals on PCP prophylaxis with CD4+ counts >200/mm3. These results suggest that HIV-1-related symptoms provide a measure of failing immune function that is not reflected by enumeration of CD4+ lymphocytes alone and support the United States Public Health Service recommendation that symptomatic individuals with CD4+ counts >200/mm3 should be considered for PCP prophylaxis.",
keywords = "Candida, Cohort studies, Fever, Pneumocystis carinii pneumonia",
author = "Kirby, {Alison J.} and Alvaro Munoz and Roger Detels and Armstrong, {John A.} and Alfred Saah and Phair, {John P.}",
year = "1994",
language = "English (US)",
volume = "7",
pages = "1242--1249",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Thrush and fever as measures of immunocompetence in HIV-1-infected men

AU - Kirby, Alison J.

AU - Munoz, Alvaro

AU - Detels, Roger

AU - Armstrong, John A.

AU - Saah, Alfred

AU - Phair, John P.

PY - 1994

Y1 - 1994

N2 - The occurrence of Pneumocystis carinii pneumonia (PCP) in human immunodeficiency virus type 1 (HIV-1)-infected individuals with high CD4+ counts indicates poor immunologic function. Thrush and persistent fever, easily recognized clinically, are potential measures of immunocompetence. This analysis establishes the complex interactions of CD4+ count, thrush, and persistent fever to predict the occurrence of PCP. Analyses used 20,632 person visits from 2,568 HIV-1-seropositive homosexual or bisexual men participating in the Multicenter AIDS Cohort Study (MACS). Comprehensive examinations were conducted semiannually, while occurrences of PCP were assessed continuously. The occurrence of thrush and fever increase in frequency as CD4+ levels decrease. The relative hazard of PCP in the presence of thrush compared with the absence of thrush rises (p <0.05) from 1 for the lowest CD4+ category to approximately 5 in the highest categories. The relative hazard of PCP in thepresence of fever compared with the absence of fever is above one (p <0.05) in all CD4+ categories. No cases of PCP occurred in individuals on PCP prophylaxis with CD4+ counts >200/mm3. These results suggest that HIV-1-related symptoms provide a measure of failing immune function that is not reflected by enumeration of CD4+ lymphocytes alone and support the United States Public Health Service recommendation that symptomatic individuals with CD4+ counts >200/mm3 should be considered for PCP prophylaxis.

AB - The occurrence of Pneumocystis carinii pneumonia (PCP) in human immunodeficiency virus type 1 (HIV-1)-infected individuals with high CD4+ counts indicates poor immunologic function. Thrush and persistent fever, easily recognized clinically, are potential measures of immunocompetence. This analysis establishes the complex interactions of CD4+ count, thrush, and persistent fever to predict the occurrence of PCP. Analyses used 20,632 person visits from 2,568 HIV-1-seropositive homosexual or bisexual men participating in the Multicenter AIDS Cohort Study (MACS). Comprehensive examinations were conducted semiannually, while occurrences of PCP were assessed continuously. The occurrence of thrush and fever increase in frequency as CD4+ levels decrease. The relative hazard of PCP in the presence of thrush compared with the absence of thrush rises (p <0.05) from 1 for the lowest CD4+ category to approximately 5 in the highest categories. The relative hazard of PCP in thepresence of fever compared with the absence of fever is above one (p <0.05) in all CD4+ categories. No cases of PCP occurred in individuals on PCP prophylaxis with CD4+ counts >200/mm3. These results suggest that HIV-1-related symptoms provide a measure of failing immune function that is not reflected by enumeration of CD4+ lymphocytes alone and support the United States Public Health Service recommendation that symptomatic individuals with CD4+ counts >200/mm3 should be considered for PCP prophylaxis.

KW - Candida

KW - Cohort studies

KW - Fever

KW - Pneumocystis carinii pneumonia

UR - http://www.scopus.com/inward/record.url?scp=0028171534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028171534&partnerID=8YFLogxK

M3 - Article

C2 - 7965635

AN - SCOPUS:0028171534

VL - 7

SP - 1242

EP - 1249

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 12

ER -